Cover Image

PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET

Abstract: the pharmacoeconomic study compared the standard drug therapy (vitamin D and phosphorbinders) of secondary hyperparathyroidism (SHPT) to the using a combination of Mimpara (Cinalcet), vitamin D and phosphorbinders in patients with end-stage renal disease on dialysis. Comparison was carried...

Full description

Saved in:

Bibliographic Details
Main Authors:	R. I. Yagudina (Author), V. G. Serpik (Author)
Format:	Book
Published:	IRBIS LLC, 2015-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cinacalcet in treatment of the secondary hyperparathyroidism relapse in patients on dialysis
by: Olga Vetchinnikova, et al.
Published: (2012)

Cinacalcet adherence in dialysis patients with secondary hyperparathyroidism in Lombardy Region: clinical implications and costs
by: Alessandro Roggeri, et al.
Published: (2020)

Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism
by: Ariadna Pérez-Ricart, et al.
Published: (2019)

Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients
by: Jeong S, et al.
Published: (2016)

THE CARDIOVASCULAR EFFECTS OF CINACALCET IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
by: Sungjin Chung, et al.
Published: (2012)

Cinacalcet versus Parathyroidectomy in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation
by: Soliman Amin R., et al.
Published: (2016)

Diameter of Parathyroid Glands Measured by Computed Tomography as a Predictive Indicator for Response to Cinacalcet in Dialysis Patients with Secondary Hyperparathyroidism
by: Yu Ah Hong, et al.
Published: (2015)

Management of pre-renal transplant secondary hyperparathyroidism: parathyroidectomy versus cinacalcet
by: Muhammed Ahmed Elhadedy, et al.
Published: (2023)

Cost-effectiveness analysis of cinacalcet versus vitamin D analogs in secondary hyperparathyroidism in end-stage renal disease patients on dialysis (Protocol)
by: Nilofar Sharahi, et al.
Published: (2017)

SEARCH OF INFORMATION IN PHARMACOECONOMIC RESEARCH
by: R. I. Yagudina, et al.
Published: (2015)

PHARMACOECONOMIC EVALUATION OF THE PROPHYLAXIS OF POSTSURGICAL INFECTIOUS INFLAMMATORY COMPLICATIONS OF COMBINED ANTIBIOTIC DRUGS AND CORTICOSTEROIDS IN OPHTHALMIC PRACTICE IN RUSSIAN FEDERATION
by: V. G. Serpik, et al.
Published: (2015)

Comparison between paricalcitol versus cinacalcet therapy in the management of secondary hyperparathyroidism among prevalent hemodialysis patients
by: Maha A. Behairy, et al.
Published: (2022)

Changes of Serum Total and Free Testosterone Concentrations in Male Chronic Hemodialysis Patients with Secondary Hyperparathyroidism in Response to Cinacalcet Treatment
by: Piotr Kuczera, et al.
Published: (2016)

Cinacalcet-Associated Resolution of Primary Hyperparathyroidism in a Patient With Normal Kidney Function
by: Son Nguyen DO, PharmD, et al.
Published: (2020)

Paricalcitol versus Calcitriol + Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in China: A Cost-Effectiveness Analysis
by: Zhuolin Zhang, et al.
Published: (2021)

Patient Flows, Patient Distribution Computations and Medicines Accounting in the Pharmacoeconomic Models Through Procurement Perspective
by: Yagudina R, et al.
Published: (2021)

Parathyroidectomy versus cinacalcet in the treatment of tertiary hyperparathyroidism after kidney transplantation: a retrospective study
by: Suyun Jung, et al.
Published: (2022)

Off-label use of cinacalcet in pediatric primary hyperparathyroidism: A French multicenter experience
by: Julie Bernardor, et al.
Published: (2022)

Pharmacoeconomic analysis of fluid therapy in the treatment of patients with peritonitis
by: R. I. Yagudina, et al.
Published: (2015)

A comparative study on the effect of calcitriol and cinacalcet on hyperparathyroidism in hemodialysis patients; a double-blinded randomized clinical trial
by: Saeed Mardani, et al.
Published: (2022)

Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease
by: Fizza Abbas, et al.
Published: (2019)

Association between ambient carbon monoxide and secondary hyperparathyroidism in nondiabetic patients undergoing peritoneal dialysis
by: Weng CH, et al.
Published: (2015)

Warfarin skin necrosis mimicking calciphylaxis in a patient with secondary hyperparathyroidism undergoing peritoneal dialysis
by: Jee Eun Park, et al.
Published: (2016)

PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH CARBONIC ANHYDRASE INHIBITORS
by: A. Yu. Kulikov, et al.
Published: (2015)

Pharmacoeconomic analysis of using Monofer in patients with iron deficiency anemia as part of the provision of medical care under the state guarantees program in the health care system of the Russian Federation
by: R. I. Yagudina, et al.
Published: (2022)

Cinacalcet Treatment Significantly Improves All-Cause and Cardiovascular Survival in Dialysis Patients: Results from a Meta-Analysis
by: Yuan Zu, et al.
Published: (2019)

Pharmacoeconomic analysis of Anti-inhibitor coagulant complex (AICC) in the treatment of inhibitor hemophilia
by: R. I. Yagudina, et al.
Published: (2015)

PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION
by: V. A. Chibilyaev, et al.
Published: (2015)

Perioperative metabolism in patients with secondary hyperparathyroidism and methods of its correction
by: A. I. Denysenko, et al.
Published: (2021)

Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide
by: Cozzolino M, et al.
Published: (2017)

PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER
by: R. I. Yagudina, et al.
Published: (2015)

PHARMACOECONOMIC STUDY OF SKIN TESTS IN THE DIAGNOSTICS OF TUBERCULOSIS INFECTION
by: R. I. Yagudina, et al.
Published: (2015)

HARMONIC SCALPEL POSSIBILITIES IN THE SURGICAL TREATMENT OF SECONDARY HYPERPARATHYROIDISM
by: Rumen Nenkov, et al.
Published: (2013)

Hypoparathyroidism versus hyperparathyroidism in pediatric dialysis patients; a single center study
by: Mitra Naseri
Published: (2017)

Pharmacoeconomic study of nutrition support in the conditions of current health care system in Russia
by: I. A. Metelkin, et al.
Published: (2015)

Iperparatiroidismo primitivo e Cinacalcet: un caso clinico
by: G. Caridi, et al.
Published: (2018)

Oral manifestations of secondary hyperparathyroidism: A case report
by: Sunita P Kakade, et al.
Published: (2015)

Laboratory criteria for the persistence of secondary hyperparathyroidism in patients with chronic kidney disease
by: M. Urina, et al.
Published: (2020)

Parathyroidectomy Reduces Intradialytic Hypotension in Hemodialysis Patients with Secondary Hyperparathyroidism
by: Chia-Jen Shih, et al.
Published: (2013)

Clinical and scanographic mandibular abnormalities in patients with secondary hyperparathyroidism on maintenance hemodialysis
by: Cheboh Cho-Fon, et al.
Published: (2021)